IP Library Granted Patent US 8,003,755
Granted Patent B2
US 8,003,755 · App. 12/082,096 · Granted Aug 23, 2011

Hydrochloride salts of a glycopeptide phosphonate derivative

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,003,755
App. No.
12/082,096
Granted
Aug 23, 2011
Kind
B2
Abstract

Disclosed are hydrochloride salts of telavancin having a chloride ion content of from about 2.4 wt. % to about 4.8 wt. %. The disclosed salts have improved stability during storage at ambient temperatures compared to other hydrochloride salts. Also disclosed are processes for preparing such salts.

Claims (9)

1. A process for preparing a hydrochloride salt of telavancin; the process comprising:

(a) forming an aqueous composition comprising a hydrochloride salt of telavancin, wherein the aqueous composition has a pH of about 3.5 to about 4.5;

(b) adding an organic diluent to the aqueous composition of step (a) to precipitate the hydrochloride salt of telavancin; and

(c) filtering the aqueous composition of step (b) to provide the hydrochloride salt of telavancin.

2. The process of claim 1 , wherein the aqueous composition has a pH of about 3.5 to about 4.0.

3. The process of claim 1 or 2 , wherein the organic diluent is acetonitrile.

4. The process of claim 1 or 2 , wherein the organic diluent is acetone.

5. The process of claim 1 or 2 , wherein the process further comprises:

(d) washing the hydrochloride salt of telavancin from step (c) with methyl tert-butyl ether.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2026
From: LIU, JYANWEI; LEE, JUNNING
To: THERAVANCE, INC.
Reel/Frame 075376/0045 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2018
From: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 047909/0853 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
Reel/Frame 033180/0571 →